DrugVision is an AI-based clinical decision support platform designed to enhance medication safety and detect adverse drug interactions. The system integrates a convolutional neural network ensemble (ResNet-50, EfficientNet-B0, MobileNetV3) for solid oral dosage form identification, transformer-augmented OCR for handwritten and printed prescription digitization, a DrugBank and openFDA knowledge graph for drug-drug interaction (DDI) risk grading, and a fine-tuned BERT architecture for clinical symptom triage, exposed via a full-stack Next.js and FastAPI architecture.
No takes yet. Share an insight, caveat, or question.
Ruparel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: